Contribution of CXCR4 and SMAD4 in predicting disease progression pattern and benefit from adjuvant chemotherapy in resected pancreatic adenocarcinoma

著录项

• 来源
  《Annals of Oncology》 |2012年第9期|p.2327-2335|共9页
• 作者

  J. B. Bachet1234*† R. Maréchal4† P. Demetter5 F. Bonnetain6 A. Couvelard7 M. Svrcek18 A. Bardier-Dupas19 P. Hammel10 A. Sauvanet11 C. Louvet11213 F. Paye114 P. Rougier215 C. Penna216 J. C. Vaillant117 T. André13 J. Closset18 I. Salmon5 J. F. Emile219 and J. L. Van Laethem4;

  展开▼
• 作者单位

  1Medical University Pierre et Marie Curie, UFR Paris VI, Paris 2EA4340 “Epidémiologie et oncogènes des tumeurs digestives”, Versailles Saint-Quentin-en-Yvelines University, Versailles 3Department of Hepato-Gastroenterology, Pitié-Salpêtrière Hospital, APHP, Paris, France 4Department of Gastroenterology, Gastrointestinal cancer Unit, Erasme Hospital, Université Libre de Bruxelles, Brussels 5Department of Pathology, Erasme Hospital, Université Libre de Bruxelles, and DiaPath, Brussels, Belgium 6Department of Biostatistic and Epidemiology (EA 4184), Georges François Leclerc Center, Dijon 7Department of Pathology, Beaujon Hospital, APHP, Clichy 8Department of Pathology, Saint Antoine Hospital, APHP, Paris 9Department of Pathology, Pitié-Salpêtrière Hospital, APHP, Paris 10Departm;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类
• 关键词